[Diagnosis, management and treatment of chronic Chagas' heart disease in areas where Trypanosoma cruzi infection is not endemic].

[1]  Sérgio Salles Xavier,et al.  Estratégias de prevenção do acidente vascular encefálico cardioembólico na doença de Chagas , 2008 .

[2]  A. Hasslocher-Moreno,et al.  Development and validation of a risk score for predicting death in Chagas' heart disease. , 2006, The New England journal of medicine.

[3]  Rodolfo Viotti,et al.  Long-Term Cardiac Outcomes of Treating Chronic Chagas Disease with Benznidazole versus No Treatment , 2006, Annals of Internal Medicine.

[4]  J. R. Coura,et al.  Consulta Técnica Regional OPS/MSF sobre Organização e Estrutura da Atenção Médica do Doente e Infectado por Trypanosoma cruzi/Doença de Chagas , 2005 .

[5]  Bruno Lococo,et al.  Indicadores clínicos de progresión de la miocarditis chagásica crónica , 2005 .

[6]  Diego F. Dávila-Spinetti,et al.  Mecanismos causantes de la progresin del dao miocrdico en la enfermedad de Chagas crnica , 2005 .

[7]  J. Gascon,et al.  Diagnóstico y tratamiento de la Enfermedad de Chagas importada , 2005 .

[8]  Joseba Achotegui.  [Emigration in hard conditions: the Immigrant Syndrome with chronic and multiple stress (Ulysses' Syndrome)]. , 2005, Vertex.

[9]  A. Hasslocher-Moreno,et al.  Prognostic Value of QT Interval Parameters for Mortality Risk Stratification in Chagas' Disease Results of a Long‐Term Follow‐Up Study , 2003, Circulation.

[10]  Á. Moncayo.  Chagas disease: current epidemiological trends after the interruption of vectorial and transfusional transmission in the Southern Cone countries. , 2003, Memorias do Instituto Oswaldo Cruz.

[11]  R. N. Herrera,et al.  Evidencia de un estado protrombótico en estadíos tempranos de la enfermedad de Chagas crónica , 2004 .

[12]  A. Sousa.  P1065 Predictive models of moderate or severe systolic dysfunction in Chagas disease based on clinical, electrocardiographic and radiological data , 2003 .

[13]  A. Porta,et al.  Power-law behavior of heart rate variability in Chagas' disease. , 2002, The American journal of cardiology.

[14]  A Prata,et al.  Clinical and epidemiological aspects of Chagas disease. , 2001, The Lancet. Infectious diseases.

[15]  Andrés Íñiguez,et al.  Guías de práctica clínica de la Sociedad Española de Cardiología en cardiología intervencionista: angioplastia coronaria y otras técnicas , 2000 .

[16]  A. d'Avila,et al.  Radiofrequency Catheter Ablation of Ventricular Tachycardia Guided by Nonsurgical Epicardial Mapping in Chronic Chagasic Heart Disease , 1999, Pacing and clinical electrophysiology : PACE.

[17]  Marin-Neto Ja.  Cardiac dysautonomia and pathogenesis of Chagas' heart disease. , 1998 .

[18]  W. Rutishauser,et al.  Chagas' disease may also be encountered in Europe. , 1996, European Heart Journal.

[19]  F. Pileggi,et al.  Heart transplantation for chronic Chagas' heart disease. , 1996, The Annals of thoracic surgery.

[20]  R. Weiss,et al.  In vivo detection of Trypanosoma cruzi antigens in hearts of patients with chronic Chagas' heart disease. , 1996, American heart journal.

[21]  P. Jc.  Natural history of Chagas disease , 1995 .

[22]  M. Kinoshita,et al.  A highly suspected case of chronic Chagas' heart disease diagnosed in Japan. , 1995, Japanese circulation journal.

[23]  B. Maciel,et al.  [Reagudization of Chagas myocarditis inducing exclusive right ventricular failure]. , 1994, Arquivos Brasileiros de Cardiologia.

[24]  F. Pileggi,et al.  Correlation between Trypanosoma cruzi parasitism and myocardial inflammatory infiltrate in human chronic chagasic myocarditis: Light microscopy and immunohistochemical findings. , 1993, Cardiovascular pathology : the official journal of the Society for Cardiovascular Pathology.

[25]  S. Yusuf,et al.  Effect of enalapril on mortality and the development of heart failure in asymptomatic patients with reduced left ventricular ejection fractions. , 1992, The New England journal of medicine.

[26]  Salim Yusuf,et al.  Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure. , 1991, The New England journal of medicine.

[27]  L. Pericchi,et al.  Prognostic indicators of chronic chagasic cardiopathy. , 1991, International journal of cardiology.

[28]  H. Ferreira,et al.  [Treatment of the undetermined form of Chagas disease with nifortimox and benzonidazole]. , 1990, Revista da Sociedade Brasileira de Medicina Tropical.

[29]  M. Rossi.  Microvascular changes as a cause of chronic cardiomyopathy in Chagas' disease. , 1990, American heart journal.

[30]  J. C. Dias.  The indeterminate form of human chronic Chagas' disease A clinical epidemiological review. , 1989, Revista da Sociedade Brasileira de Medicina Tropical.

[31]  J. Maguire,et al.  Cardiac morbidity and mortality due to Chagas' disease: prospective electrocardiographic study of a Brazilian community. , 1987, Circulation.

[32]  H. Acquatella,et al.  Echocardiographic features of impaired left ventricular diastolic function in Chagas's heart disease. , 1985, British heart journal.

[33]  G. Nau,et al.  Efficacy of amiodarone during long-term treatment of malignant ventricular arrhythmias in patients with chronic chagasic myocarditis. , 1984, American heart journal.

[34]  J. Samuel,et al.  Cardiac thrombosis and thromboembolism in chronic Chagas' heart disease. , 1983, The American journal of cardiology.

[35]  E. C. Lima Filho,et al.  Apical aneurysm of Chagas's heart disease. , 1981, British heart journal.

[36]  N. Schiller,et al.  M-mode and two-dimensional echocardiography in chronic Chages' heart disease. A clinical and pathologic study. , 1980, Circulation.

[37]  J. Dias,et al.  The prognostic value of the electrocardiographic features of chronic Chagas' disease. , 1968, Revista do Instituto de Medicina Tropical de Sao Paulo.

[38]  F. Laranja,et al.  Chagas' Disease: A Clinical, Epidemiologic, and Pathologic Study , 1956, Circulation.

[39]  R. Bonfante-Cabarcas,et al.  [C-reactive protein and interleukin-6 serum levels increase as Chagas disease progresses towards cardiac failure]. , 2006, Revista espanola de cardiologia.

[40]  L. López,et al.  Las concentraciones séricas de interleucina-6 y proteína C reactiva se incrementan a medida que la enfermedad de Chagas evoluciona hacia el deterioro de la función cardíaca , 2006 .

[41]  M. Siqueira,et al.  [Respiratory syncytial virus -- associated lower respiratory tract infections in hospitalized infants]. , 2005, Revista da Sociedade Brasileira de Medicina Tropical.

[42]  A. Rassi,et al.  Sudden death in Chagas' disease. , 2001, Arquivos Brasileiros de Cardiologia.

[43]  W. Tafuri.  Immunopathology of Chagas disease - a historical overview. , 1999, Memorias do Instituto Oswaldo Cruz.

[44]  H. F. Neto,et al.  Considerations on the epidemiology and transmission of Chagas disease in the Brazilian Amazon. , 1999, Memorias do Instituto Oswaldo Cruz.

[45]  J. Marin-Neto.  Cardiac dysautonomia and pathogenesis of Chagas' heart disease. , 1998, International Journal of Cardiology.

[46]  J. C. Pinto Dias.  [Natural history of Chagas disease]. , 1995, Arquivos brasileiros de cardiologia.

[47]  Maria Gabriela Mendoza Sassi,et al.  Forma indeterminada da Doença de Chagas , 1991 .

[48]  Richard J. Hayes,et al.  Estimación de las tasas de incidencia de infecciones y parasitosis crónicas a partir de la prevalencia: La enfermedad de Chagas en América Latina , 1990 .

[49]  G. Takle,et al.  Autoimmunity and Chagas' disease. , 1989, Current topics in microbiology and immunology.

[50]  A. Prata,et al.  Características da morte súbita tida como não esperada na doença de Chagas , 1986 .

[51]  C. Chagas.  Pathogenic Processes of American Trypanosomiasis. , 2022 .